INS and type 1 diabetes mellitus: Cell-based therapy has opened a new corridor for T1D therapy, as beta-like cells or insulin-producing cells (IPCs) have been successfully induced in laboratories (Kopan et al., 2018; Espona-Noguera and Ciriza, 2019).